nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—HTR2A—narcolepsy	0.862	1	CbGaD
Droperidol—HTR2A—enteric nervous system—narcolepsy	0.0193	0.267	CbGeAlD
Droperidol—HTR2A—locus ceruleus—narcolepsy	0.0127	0.176	CbGeAlD
Droperidol—HTR2A—pons—narcolepsy	0.00735	0.102	CbGeAlD
Droperidol—HTR2A—autonomic nervous system—narcolepsy	0.00677	0.0937	CbGeAlD
Droperidol—ADRA1A—brainstem—narcolepsy	0.00253	0.035	CbGeAlD
Droperidol—DRD2—brainstem—narcolepsy	0.00248	0.0343	CbGeAlD
Droperidol—ADRA1A—forebrain—narcolepsy	0.00244	0.0338	CbGeAlD
Droperidol—DRD2—forebrain—narcolepsy	0.00239	0.0331	CbGeAlD
Droperidol—KCNH2—forebrain—narcolepsy	0.00236	0.0326	CbGeAlD
Droperidol—KCNH2—medulla oblongata—narcolepsy	0.0017	0.0236	CbGeAlD
Droperidol—HTR2A—brainstem—narcolepsy	0.00164	0.0226	CbGeAlD
Droperidol—DRD2—midbrain—narcolepsy	0.00158	0.0219	CbGeAlD
Droperidol—HTR2A—forebrain—narcolepsy	0.00158	0.0218	CbGeAlD
Droperidol—KCNH2—midbrain—narcolepsy	0.00156	0.0215	CbGeAlD
Droperidol—Fluspirilene—HTR2A—narcolepsy	0.00147	0.412	CrCbGaD
Droperidol—DRD2—Amine ligand-binding receptors—HRH3—narcolepsy	0.00135	0.0218	CbGpPWpGaD
Droperidol—HTR2A—Amine ligand-binding receptors—HRH3—narcolepsy	0.00133	0.0215	CbGpPWpGaD
Droperidol—ADRA1A—Amine ligand-binding receptors—HRH3—narcolepsy	0.0013	0.021	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Other—P2RY11—narcolepsy	0.00124	0.0201	CbGpPWpGaD
Droperidol—ADRA1A—AMPK Signaling—CPT1B—narcolepsy	0.00121	0.0196	CbGpPWpGaD
Droperidol—HTR2A—medulla oblongata—narcolepsy	0.00114	0.0158	CbGeAlD
Droperidol—Pimozide—HTR2A—narcolepsy	0.0011	0.308	CrCbGaD
Droperidol—HTR2A—midbrain—narcolepsy	0.00104	0.0144	CbGeAlD
Droperidol—ADRA1A—brain—narcolepsy	0.00101	0.014	CbGeAlD
Droperidol—Haloperidol—HTR2A—narcolepsy	0.001	0.281	CrCbGaD
Droperidol—DRD2—brain—narcolepsy	0.000993	0.0137	CbGeAlD
Droperidol—KCNH2—brain—narcolepsy	0.000978	0.0135	CbGeAlD
Droperidol—DRD2—Monoamine GPCRs—HTR2A—narcolepsy	0.000802	0.0129	CbGpPWpGaD
Droperidol—ADRA1A—Monoamine GPCRs—HTR2A—narcolepsy	0.000772	0.0125	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.000724	0.0117	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.000724	0.0117	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.000709	0.0114	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.000709	0.0114	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—P2RY11—narcolepsy	0.000699	0.0113	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000698	0.0113	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—HCRTR2—narcolepsy	0.000694	0.0112	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—HCRTR1—narcolepsy	0.000694	0.0112	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—P2RY11—narcolepsy	0.000685	0.0111	CbGpPWpGaD
Droperidol—DRD2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.000674	0.0109	CbGpPWpGaD
Droperidol—HTR2A—brain—narcolepsy	0.000655	0.00906	CbGeAlD
Droperidol—ADRA1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.000649	0.0105	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.000647	0.0105	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.000647	0.0105	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.000634	0.0102	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.000634	0.0102	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.000625	0.0101	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.000612	0.00988	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—HCRT—narcolepsy	0.000594	0.0096	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—HCRT—narcolepsy	0.000582	0.0094	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000569	0.00918	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000569	0.00918	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00056	0.00903	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00056	0.00903	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000549	0.00887	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000548	0.00885	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000548	0.00885	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00054	0.00872	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.000532	0.00858	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000529	0.00854	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.000521	0.0084	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000487	0.00787	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000487	0.00787	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000479	0.00774	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000479	0.00774	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000471	0.0076	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000469	0.00758	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000469	0.00758	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000463	0.00747	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000453	0.00732	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—TRH—narcolepsy	0.00045	0.00727	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—PENK—narcolepsy	0.000449	0.00724	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—TRH—narcolepsy	0.000441	0.00712	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00042	0.00678	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.000403	0.0065	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0004	0.00646	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.000395	0.00637	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000394	0.00636	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000385	0.00622	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000378	0.00611	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—HCRTR2—narcolepsy	0.000371	0.00599	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—HCRTR1—narcolepsy	0.000371	0.00599	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—HCRTR2—narcolepsy	0.000365	0.00589	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—HCRTR1—narcolepsy	0.000365	0.00589	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—P2RY11—narcolepsy	0.000358	0.00578	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.000357	0.00577	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.000357	0.00577	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000357	0.00576	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—P2RY11—narcolepsy	0.000353	0.00569	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000351	0.00566	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.000345	0.00557	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000344	0.00555	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—HRH3—narcolepsy	0.000334	0.0054	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—TAC1—narcolepsy	0.000327	0.00528	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—NPS—narcolepsy	0.000327	0.00528	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.00032	0.00517	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00032	0.00517	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—NPS—narcolepsy	0.000314	0.00507	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00031	0.00501	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000305	0.00493	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—HCRT—narcolepsy	0.000305	0.00492	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000303	0.0049	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—HCRT—narcolepsy	0.0003	0.00484	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000299	0.00483	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000298	0.00482	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.000294	0.00474	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000293	0.00473	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000293	0.00473	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000292	0.00472	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000287	0.00463	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000287	0.00463	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—PENK—narcolepsy	0.000272	0.00438	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—PENK—narcolepsy	0.000267	0.00431	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000266	0.00429	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.000262	0.00422	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000262	0.00422	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000256	0.00414	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—TRH—narcolepsy	0.000231	0.00373	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—TRH—narcolepsy	0.000227	0.00367	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.000222	0.00359	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00022	0.00356	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00022	0.00356	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000217	0.0035	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000217	0.0035	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000212	0.00343	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000212	0.00343	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00021	0.00338	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00021	0.00338	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000206	0.00333	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000206	0.00333	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—P2RY11—narcolepsy	0.000202	0.00327	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—HRH3—narcolepsy	0.000202	0.00327	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000202	0.00326	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000202	0.00326	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000199	0.00322	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—HRH3—narcolepsy	0.000199	0.00322	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.000195	0.00315	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.000195	0.00315	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.000193	0.00311	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HCRTR2—narcolepsy	0.00019	0.00307	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HCRTR1—narcolepsy	0.00019	0.00307	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000187	0.00302	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000187	0.00302	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—P2RY11—narcolepsy	0.000184	0.00297	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.000183	0.00296	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.000183	0.00296	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—P2RY11—narcolepsy	0.000181	0.00292	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000181	0.00292	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.000177	0.00286	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000172	0.00278	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—HCRT—narcolepsy	0.000172	0.00278	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—HCRT—narcolepsy	0.000169	0.00274	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—NPS—narcolepsy	0.000168	0.00271	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—TAC1—narcolepsy	0.000168	0.00271	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.000166	0.00268	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—TAC1—narcolepsy	0.000165	0.00267	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—NPS—narcolepsy	0.000165	0.00267	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.000162	0.00261	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.000162	0.00261	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HCRT—narcolepsy	0.000156	0.00252	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000155	0.0025	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—HCRT—narcolepsy	0.000154	0.00248	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PENK—narcolepsy	0.000153	0.00248	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PENK—narcolepsy	0.000151	0.00244	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.000151	0.00243	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000149	0.00241	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.000148	0.00239	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PENK—narcolepsy	0.000139	0.00225	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PENK—narcolepsy	0.000137	0.00221	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.000134	0.00217	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000133	0.00214	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—TRH—narcolepsy	0.00013	0.00211	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—TRH—narcolepsy	0.000128	0.00207	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000128	0.00206	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.000126	0.00203	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—TRH—narcolepsy	0.000118	0.00191	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—TRH—narcolepsy	0.000117	0.00188	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—HRH3—narcolepsy	0.000114	0.00185	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.000114	0.00184	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—HRH3—narcolepsy	0.000113	0.00182	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HCRTR1—narcolepsy	0.000112	0.00182	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HCRTR2—narcolepsy	0.000112	0.00182	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HCRTR1—narcolepsy	0.000111	0.00179	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HCRTR2—narcolepsy	0.000111	0.00179	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.00011	0.00178	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—P2RY11—narcolepsy	0.000109	0.00175	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.000108	0.00175	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.000108	0.00175	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—P2RY11—narcolepsy	0.000107	0.00173	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.000105	0.00169	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HRH3—narcolepsy	0.000104	0.00168	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—HRH3—narcolepsy	0.000102	0.00165	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—HTR2A—narcolepsy	0.000101	0.00163	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.0001	0.00162	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—TNF—narcolepsy	9.79e-05	0.00158	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	9.72e-05	0.00157	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—TAC1—narcolepsy	9.48e-05	0.00153	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—NPS—narcolepsy	9.48e-05	0.00153	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—TAC1—narcolepsy	9.33e-05	0.00151	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—NPS—narcolepsy	9.33e-05	0.00151	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HCRT—narcolepsy	9.24e-05	0.00149	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	9.13e-05	0.00147	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	9.13e-05	0.00147	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HCRT—narcolepsy	9.09e-05	0.00147	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HCRT—narcolepsy	8.9e-05	0.00144	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—TAC1—narcolepsy	8.61e-05	0.00139	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—NPS—narcolepsy	8.61e-05	0.00139	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—TAC1—narcolepsy	8.47e-05	0.00137	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—NPS—narcolepsy	8.47e-05	0.00137	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—NPS—narcolepsy	8.29e-05	0.00134	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	8.29e-05	0.00134	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PENK—narcolepsy	8.23e-05	0.00133	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PENK—narcolepsy	8.1e-05	0.00131	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PENK—narcolepsy	7.93e-05	0.00128	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TRH—narcolepsy	7e-05	0.00113	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TRH—narcolepsy	6.89e-05	0.00111	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TRH—narcolepsy	6.74e-05	0.00109	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HRH3—narcolepsy	6.14e-05	0.000991	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HRH3—narcolepsy	6.04e-05	0.000975	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HRH3—narcolepsy	5.91e-05	0.000955	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—HTR2A—narcolepsy	5.7e-05	0.000921	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	5.5e-05	0.000887	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HTR2A—narcolepsy	5.18e-05	0.000836	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TAC1—narcolepsy	5.09e-05	0.000821	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NPS—narcolepsy	5.09e-05	0.000821	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TAC1—narcolepsy	5e-05	0.000808	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NPS—narcolepsy	5e-05	0.000808	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	4.99e-05	0.000806	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TAC1—narcolepsy	4.9e-05	0.000791	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NPS—narcolepsy	4.9e-05	0.000791	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR2A—narcolepsy	3.06e-05	0.000494	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	2.95e-05	0.000476	CbGpPWpGaD
